Hypoproteinemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.According to the criteria specified in the 8th edition of Internal Medicine, a diagnosis of hypoproteinemia? is confirmed when serum albumin is < 35 g/L; 2.Judged by the clinical physician, the disease causing hypoproteinemia is in a relatively stable phase; 3.Voluntarily participated in the study and signed the informed consent form; 4.Adults aged 18-80, both men and women.
Exclusion criteria
Exclusion criteria: 1.Known history of allergy or intolerance to any ingredient in this protein supplement; 2.Pregnant and lactating women, as well as individuals planning to become pregnant during the trial period; 3.Individuals with severe heart disease, severe liver failure (e.g., Child-Pugh class C), severe renal insufficiency (e.g., requiring dialysis), or other severe organic diseases; 4.Individuals currently using immunosuppressants such as glucocorticoids or immunosuppressive agents (e.g., cyclosporine, tacrolimus); 5.Individuals with albumin/globulin (A/G) ratio 3.5g/24h); 9.Individuals with moderate or severe anemia; 10.Individuals in a state of low immunity, such as AIDS patients or those with other immunodeficiency diseases; 11.Individuals with severe metabolic disorders, such as poorly controlled diabetes (HbA1c > 9%) or thyroid dysfunction (e.g., hyperthyroidism or hypothyroidism); 12.Patient for whom the specific cause of hypoproteinemia cannot be determined; 13.Investigator deems the subject to have poor compliance, or the investigator believes the subject is unsuitable to participate in this trial for any other reason;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Immune Function;Haematological parameters;Kidney function;Grip strength;Nutritional Prognostic Index; | — |
Countries
China
Contacts
Wuxi people’s Hospital